Drug
Rbp 7000
Rbp 7000: highest development phase Phase 3, developed by Indivior. 4 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Indivior
Trials
| Drug | Phase | Indication |
|---|---|---|
| RBP-7000 NCT02203838 | Phase 3 | Schizophrenia |
| RBP-7000 NCT02109562 | Phase 3 | Schizophrenia |
| RBP-7000 NCT02687984 | Phase 1 | Schizophrenia |
| RBP-7000 NCT02768649 | Phase 1 | Schizophrenia |
Latest
No recent events.
Follow Rbp 7000 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.